Hypertonic Saline: Medical Uses, Concentrations, and Risks

Hypertonic saline is any salt solution with a sodium chloride concentration higher than the body’s own fluids, and it works by pulling water out of swollen tissues through osmosis. In medicine, concentrations typically range from 2% to 23.4%, compared with the 0.9% “normal” saline that matches blood plasma. That ability to draw water across cell membranes makes hypertonic saline useful in a surprisingly wide range of clinical situations, from relieving dangerous brain swelling to helping children with cystic fibrosis breathe easier. But the same osmotic force that makes it therapeutic can cause serious harm if the dose, speed, or monitoring goes wrong.

How Hypertonic Saline Works in the Body

The core principle is simple: when you introduce a saltier-than-normal solution into the bloodstream, water moves from areas of lower salt concentration to areas of higher concentration. Cells and tissues that are waterlogged begin surrendering their excess fluid into the blood vessels. This single mechanism produces several downstream effects that clinicians exploit depending on the situation.

The first and most immediate effect is plasma volume expansion. In a study comparing 7.5% hypertonic saline against normal saline and a starch-based fluid after cardiac surgery, researchers found that the increase in extracellular water with hypertonic saline actually exceeded the volume that was infused, because additional water was recruited from inside cells.¹ In other words, a small bag of concentrated salt solution can do the expanding work of a much larger volume of regular fluid.

Beyond moving water, hypertonic saline appears to tamp down inflammation. In laboratory studies using human lung cells, exposing inflamed tissue to hypertonic saline reduced the chemical signals that recruit immune cells to the area, effectively cooling down the inflammatory response.² It also shrinks the cells lining blood vessels, which improves blood flow through tiny capillaries that become clogged during shock or injury.³ And at the microvascular level, higher sodium concentrations reduce leakiness in activated blood vessel walls in a dose-dependent manner, meaning the saltier the solution, the tighter the vessel walls become.⁴

Reducing Brain Swelling After Injury

The use that generates the most attention in critical care is controlling elevated intracranial pressure. When the brain swells after a traumatic injury, stroke, or other insult, pressure inside the skull rises and can quickly become life-threatening. Hypertonic saline draws water out of swollen brain tissue and into the bloodstream, shrinking the brain just enough to relieve that pressure.

For decades, mannitol was the default drug for this purpose. The question of whether hypertonic saline is better has been studied extensively, and the honest answer is: it depends on what you measure. A systematic review of 14 studies in patients with non-traumatic brain injuries found that seven studies rated hypertonic saline superior to mannitol for lowering intracranial pressure, while three found them equally effective.⁵ In traumatic brain injury specifically, a separate meta-analysis found similar pressure reduction between the two drugs but noted that hypertonic saline produced a longer-lasting effect and was associated with shorter ICU stays, even though mortality rates and neurological outcomes were comparable.⁶ Yet another meta-analysis on traumatic brain injury concluded that the two drugs are “equally effective” and that neither showed a clear mortality advantage.⁷

In children with severe traumatic brain injury, hypertonic saline reliably lowers intracranial pressure, but the response may vary with the child’s ultimate prognosis. One study found the pressure-lowering effect was significantly greater and longer-lasting in children who went on to have favorable outcomes, and those same children showed restored autoregulation of blood flow in the brain, something not seen in children with poor outcomes.⁸ A pediatric meta-analysis reported a time-dependent drop in intracranial pressure after hypertonic saline: a large decrease at 30 minutes that continued falling through 60 minutes and remained lower at 24 hours. Mortality in children treated with hypertonic saline was around 17%, and no significant mortality difference was found compared with mannitol.⁹

One scenario where hypertonic saline has not proven helpful is prehospital resuscitation of trauma patients. A randomized trial giving a 7.5% bolus to patients with severe traumatic brain injury and low blood pressure found virtually identical neurological outcomes at six months compared with standard fluids.¹⁰ Despite that, some guidelines still recommend it for patients showing signs of imminent brain herniation in the field, essentially treating it as a bridge until they reach a hospital.¹¹

Clearing Mucus in Cystic Fibrosis

In the lungs of people with cystic fibrosis, mucus becomes thick and sticky because the airway surfaces are chronically dehydrated. Inhaling nebulized hypertonic saline, usually at 3% to 7% concentration, draws water onto those surfaces and rehydrates the mucus, making it easier to cough out. This is one of the better-established uses of hypertonic saline, supported by a Cochrane review confirming the mechanism.¹²

Dose matters. A study testing 3%, 7%, and 12% hypertonic saline in cystic fibrosis patients found that all three concentrations significantly improved mucus clearance from the lungs compared with a control, and the improvement grew with concentration. The amount of mucus cleared at 90 minutes roughly doubled with 12% compared with control.¹³ The clearance was not simply from coughing, either, since patients actually coughed more on the control day than on the treatment days.

Longer-term use shows sustained benefits. A trial published in the New England Journal of Medicine found that regular inhalation of hypertonic saline produced a mucus clearance rate that remained elevated for over eight hours after a single session and improved lung function as measured by breathing tests. The average improvement in a key lung function measure was about 7% over baseline.¹⁴ The sustained hydration of the airway surface, rather than a brief osmotic burst, appeared to be responsible for the lasting benefit.

Bronchiolitis in Infants

Nebulized hypertonic saline has also been studied extensively in infants hospitalized with viral bronchiolitis, a common winter illness where the small airways become inflamed and clogged with mucus. The reasoning is similar to cystic fibrosis: draw water into the airways, thin the mucus, help the baby breathe. A Cochrane review covering 21 trials and nearly 2,500 infants found that those treated with nebulized hypertonic saline had a hospital stay about 0.4 days shorter than infants receiving normal saline or standard care, though the evidence was rated low-certainty.¹⁵

Individual trials have been more optimistic. One early study found that 3% saline combined with epinephrine cut hospitalization by about 25% compared with normal saline plus epinephrine.¹⁶ A later randomized trial found that the admission rate from the emergency department was lower in the hypertonic saline group (about 29%) than in the normal saline group (about 43%).¹⁷ The reality is that the benefit, while consistent in direction, is modest in size. Whether hospitals adopt it as routine practice often depends on local guidelines and whether the treatment can be delivered easily in a busy pediatric ward.

Heart Failure and Stubborn Fluid Overload

Adding hypertonic saline to heart failure treatment sounds counterintuitive. Patients are drowning in fluid, so why give them salt? The logic becomes clearer when you understand the problem: in severe, decompensated heart failure, the kidneys stop responding to diuretics. Sodium levels drop, the kidneys retain even more water, and a vicious cycle sets in. A small amount of hypertonic saline can break that cycle by raising the sodium level and restoring the kidneys’ ability to respond to diuretics.

A randomized trial compared high-dose furosemide combined with a small-volume hypertonic saline infusion against furosemide alone in patients with the most severe class of heart failure. The combination group produced much more urine and excreted more sodium. Their blood sodium levels rose while the furosemide-only group’s actually fell. The combination group also had shorter hospital stays (roughly 9 days versus 12) and, strikingly, none were readmitted over 6 to 12 months of follow-up.¹⁸ A follow-up double-blind study by the same research group confirmed that the hypertonic saline group achieved better fluid removal, better hydration markers, and lower levels of the heart failure biomarker BNP, along with reduced hospitalization time and readmission rates.¹⁹

A real-world U.S. study confirmed the pattern in everyday clinical practice. In patients whose heart failure was truly refractory to standard diuretic dosing, adding hypertonic saline improved urine output, weight loss, and diuretic efficiency, and corrected worsening sodium, chloride, and creatinine levels without any adverse respiratory or neurological events.²⁰ This use has grown in popularity among cardiologists, though it remains somewhat niche and is mostly reserved for patients who have failed conventional approaches.

Treating Dangerously Low Sodium

Hyponatremia, when blood sodium drops too low, can cause confusion, seizures, and even death. Hypertonic saline is the standard treatment for symptomatic cases because it directly replaces the missing sodium. The tricky part is how fast to give it.

A study comparing bolus (concentrated burst) versus continuous infusion of 3% saline in patients with low sodium found that the bolus approach raised sodium levels faster, with a corresponding quicker improvement in neurological status measured by standard consciousness scales. By 24 hours, sodium levels were similar between the two methods. Neither group developed osmotic demyelination, the dreaded complication of correcting sodium too quickly.²¹ However, patients who received a third bolus dose were far more likely to need rescue treatment to prevent overcorrection, suggesting that aggressive bolusing carries its own risk.

A real-life observational study of patients treated for symptomatic hyponatremia found that those receiving hypertonic saline tended to have lower starting sodium levels than those managed conventionally. The most common symptoms in moderately low cases were dizziness, while more severe cases presented with vomiting and drowsiness.²²

The Risk of Correcting Sodium Too Fast

Osmotic demyelination syndrome is the complication that keeps clinicians up at night when administering hypertonic saline for low sodium. When sodium rises too rapidly, brain cells that had adapted to the low-sodium environment suddenly shrink as water is pulled out of them. This damages the insulating coating around nerve fibers, particularly in the brainstem, and can cause devastating neurological injury.

A systematic review found that osmotic demyelination occurred in less than 1% of patients whose sodium was corrected rapidly and about 0.1% of those without rapid correction. The average baseline sodium in patients who developed the syndrome was extremely low, around 109 mmol/L. Common risk factors included alcohol use, malnutrition, low potassium, and severely depressed starting sodium, and these risk factors were present even in patients who developed the syndrome without overly rapid correction.²³ The syndrome is more likely after treatment of chronic hyponatremia (developing over days or weeks) than acute cases, because chronic adaptation is what makes the brain vulnerable to rapid reversal.²⁴ Patients with alcohol use disorder are at particular risk, as illustrated by case reports documenting the syndrome even with seemingly careful management.²⁵

Kidney Stress and Chloride Overload

For patients receiving hypertonic saline over days, particularly in neurological ICUs where it is used as a continuous infusion to control brain swelling, the chloride load can become a problem. Sodium chloride delivers both sodium and chloride, and the chloride accumulation can itself damage the kidneys.

A study of 142 neurologically injured patients found that 38% developed high chloride levels and 13% developed acute kidney injury. Patients who received more than about 2,000 milliequivalents of chloride over seven days were significantly more likely to develop kidney injury.²⁶ A retrospective study of traumatic brain injury patients confirmed the association: every 1 mEq/L increase in peak chloride was linked to roughly 10% higher odds of developing kidney injury, and patients in the kidney injury group had universally high chloride levels.²⁷ This is why ICU teams monitor chloride levels closely alongside sodium when using prolonged hypertonic saline infusions.

Peripheral Versus Central Line Delivery

Traditionally, hypertonic saline at concentrations above 3% was considered too caustic for a regular IV in the arm and required a central venous catheter threaded into a large vein near the heart. Central lines, though, carry their own serious risks: bloodstream infections, blood clots, punctured lungs during insertion. The field has been reassessing whether a peripheral IV can safely deliver 3% saline, and the evidence increasingly says yes, at least for short durations.

A systematic review and meta-analysis comparing the two routes found that complication rates were actually higher with central lines. Complications from peripheral administration, such as vein irritation or fluid leaking into surrounding tissue, were generally mild and manageable, often resolved just by repositioning the catheter.²⁸ Another study found that adverse events with peripheral 3% saline occurred more often when the infusion ran for a longer duration, and the majority of those events were mild with no permanent tissue injury.²⁹ Many emergency departments now give short boluses of 3% saline through a peripheral IV without hesitation, though concentrations above 3% still generally warrant a central line.

Small-Volume Resuscitation in Hemorrhagic Shock

The idea of using a tiny volume of very concentrated saline to resuscitate someone who is bleeding out has fascinated trauma researchers since the 1980s. In an early animal study, a small injection of 2,400 mOsm/L hypertonic saline after hemorrhagic shock raised blood pressure by about 48 mm Hg, recovered cardiac output to 95% of normal, and expanded plasma volume by roughly 360 mL within minutes, all without large fluid volumes.³⁰ Laboratory studies have shown that hypertonic saline mixed with dextran or starch outperforms standard lactated Ringer’s solution in restoring blood flow through the liver’s tiny vessels after shock, partly by shrinking swollen cells lining those vessels.³¹ Hypertonic saline also appears more effective than standard fluid at limiting lung injury and the activation of inflammatory white blood cells after trauma.³²

The frustrating part is that these promising lab and animal results have not translated cleanly into survival benefits in human trials. A review of the clinical evidence found controversial results overall, with some support for reduced inflammation but no clear mortality advantage over other resuscitation fluids, and a concern about impaired blood clotting.³³ The concept of small-volume resuscitation remains appealing for military and remote settings where carrying large fluid volumes is impractical, but it has not displaced balanced crystalloids as the standard of care in civilian trauma.

Hypertonic Saline Eye Drops for Corneal Swelling

Outside of critical care, hypertonic saline shows up in a form most people can buy at a pharmacy: 5% sodium chloride eye drops or ointment. These work by the same osmotic principle, drawing excess water out of a swollen cornea. The results depend heavily on what is causing the swelling.

A review of the literature found limited benefit for bullous keratopathy, a condition involving blistering on the corneal surface, but meaningful clinical improvement in corneal swelling without surface breakdown, particularly in Fuchs dystrophy and a condition called corneal hydrops in keratoconus.³⁴ After cataract surgery, which commonly causes temporary corneal swelling, a randomized trial found that 5% hypertonic saline drops produced faster reduction in swelling, better visual acuity, and clearer subjective vision within a week compared with placebo drops, with no adverse events.³⁵ Over 90% of patients using hypertonic saline drops reported clear vision at one week, compared with about 57% in the placebo group.

Different Concentrations and When Each Is Used

Not all hypertonic saline is the same, and the concentration chosen depends on the clinical goal. At the lower end, 2% to 3% solutions are used for nebulization in respiratory conditions and for gentle sodium correction in hyponatremia. At 3%, the solution can typically be given through a peripheral IV for short periods. A study comparing 5% against 3% hypertonic saline in neurosurgical patients found that the 5% group maintained higher blood osmolarity and sodium levels over 72 hours, which may matter when tighter control of brain swelling is needed.³⁶

At 7.5%, the solution enters the territory of small-volume resuscitation and prehospital care. At the extreme end, 23.4% hypertonic saline is sometimes used in neurosurgical emergencies for patients with acutely life-threatening brain herniation. This concentrated formulation must be given through a central line and in a closely monitored setting, since even small volumes produce dramatic shifts in sodium and fluid balance. The general pattern is that higher concentrations produce stronger and faster osmotic effects but also carry greater risk, making monitoring and appropriate vascular access more important as you move up the scale.

Subarachnoid Hemorrhage and Vasospasm

A less well-known application is in patients who have had bleeding around the brain from a ruptured aneurysm. These patients frequently develop vasospasm, where blood vessels in the brain clamp down dangerously, and often become hyponatremic at the same time. Using 3% saline to correct the low sodium while maintaining higher fluid volumes in the blood vessels has shown promise. In a series of 29 hyponatremic patients with vasospasm after subarachnoid hemorrhage, a continuous 3% saline infusion raised sodium levels and maintained higher central venous pressures and positive fluid balance without causing heart failure, lung fluid overload, or osmotic demyelination.³⁷ Animal research has gone further, suggesting that a hypertonic solution combined with starch can actually reduce the vessel wall thickening that causes vasospasm, partly by preventing the death of smooth muscle cells in the vessel walls.³⁸ This is early-stage evidence, but it points to hypertonic saline having effects beyond simple water movement in the brain’s vascular system.